Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0019158 (hepatitis)
 30,205 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A summary is given on the local and general risks of blood donation for the donor and especially on the recipient's risks to blood transfusion itself, including massive transfusion. The transfusion reactions are grouped in (1) risks in connection with the technique and physics of transfusion (cooling, air embolism, microaggregation, circulatory overload), (2) biochemical-metabolic risks (citrate intoxication, acidity, coagulation deficiencies), (3) immunological-serological risks (allergic and hemolytic reaction, addendum: pyrogenic reaction), (4) dangers of infection (bacteria: septic-toxic reaction, protozoae: malaria, viruses: herpes group, cytomegaly, hepatitis). In order to cut down the overall frequency of transfusion reactions, the use of blood derivatives instead of whole blood has been described.
 ...
PMID:[Risks to donor and recipient in blood collection and blood transfusion]. 55 63

Inorganic bismuth salts are poorly soluble in water: solubility is influenced by the acidity of the medium and the presence of certain compounds with (hydr)oxy or sulfhydryl groups. The analysis of bismuth in biological material is not standardised and is subject to large variation; it is difficult to compare data from different studies, and older data should be approached with caution. The normal concentration of bismuth in blood is between 1 and 15 micrograms/L, but absorption from oral preparations produces a significant rise. Distribution of bismuth in the organs is largely independent of the compound administered or the route of administration: the concentration in kidney is always highest and the substance is also retained there for a long time. It is bound to a bismuth-metal binding protein in the kidney, the synthesis of which can be induced by the metal itself. Elimination from the body takes place by the urinary and faecal routes, but the exact proportion contributed by each route is still unknown. Elimination from blood displays multicompartment pharmacokinetics, the shortest half-life described in humans being 3.5 minutes, and the longest 17 to 22 years. A number of toxic effects have been attributed to bismuth compounds in humans: nephropathy, encephalopathy, osteoarthropathy, gingivitis, stomatitis and colitis. Whether hepatitis is a side effect, however, is open to dispute. Each of these adverse effects is associated with certain bismuth compounds. Bismuth encephalopathy occurred in France as an epidemic of toxicity and was associated with the intake of inorganic salts including bismuth subnitrate, subcarbonate and subgallate. In the prodromal phase patients developed problems in walking, standing or writing, deterioration of memory, changes in behaviour, insomnia and muscle cramps, together with several psychiatric symptoms. The manifest phase started abruptly and was characterised by changes in awareness, myoclonia, astasia and/or abasia and dysarthria. Patients recovered spontaneously after discontinuation of bismuth. Intestinal lavage, forced diuresis and haemodialysis have been tried without positive effects on the clinical condition of the patient or on blood bismuth concentration, and the use of dimercaprol as an antidote has produced reports of both positive and negative findings. To confirm the diagnosis of bismuth encephalopathy, it is essential to find elevated bismuth concentrations in blood, plasma, serum or CSF. A safety level of 50 micrograms/L and an alarm level of 100 micrograms/L have been suggested in the past, but no proof is available to support the choice of these levels.(ABSTRACT TRUNCATED AT 400 WORDS)
 ...
PMID:Pharmacokinetics and toxicity of bismuth compounds. 268 29

The effect of the complications of duodenal ulcer on the rate of gastric secretion and acidity was studied under the conditions of maximum stimulation with pentagastrin. A total of 440 patients were studied. It has been established that the volume of gastric secretion and acid secretion are significantly higher in complications than in the absence of complications. The elevated values of gastric secretion and acid production in the patients with complicated duodenal ulcer are determined by their predominant elevation in case of past perforations and in case of stenosis of pylorus in particular. As compared with the patients without complications, the patients with the two indicated complications have 1.11 to 1.42 and 1.15 to 1.92 times higher indices respectively. The elevation of the parameters in past histories of gastrointestinal hemorrhages is rather small. The chronic reactive hepatitis, originating as a complication of duodenal ulcer, has lower values of gastric secretion and acidity as compared with the non-complicated form of the disease. The mean values, however, of none of the indices drop under the norm but range within the upper physiological limits.
 ...
PMID:[Effect of complications on the rate of gastric secretion and acidity in duodenal ulcer]. 360 92

The Hepatitis Delta Virus (HDV) ribozyme was the first RNA enzyme proposed to use a proton-transfer mechanism for catalysis. Previous biochemical evidence suggested that the genomic HDV ribozyme promotes cis-cleavage using cytosine 75 whose pK(a) is perturbed within the active site. Here we present further biochemical evidence for the involvement of C75 in proton transfer, as well as evidence to support a plausible mechanism for C75 pK(a) perturbation. Nucleotide analogue interference mapping (NAIM) experiments with C analogues having altered N3 pK(a)s demonstrate the importance of C75 ionization in the HDV cis-cleavage reaction. pH-dependent interference rescue with C analogues having enhanced N3 acidity indicates that C75 is the only cytidine residue that must be protonated for ribozyme activity. Furthermore, interference analysis with pseudoisocytidine, a charge-neutral mimic of a C with a protonated N3, shows a pattern consistent with proton transfer, possibly from the C75 N3 to the 5'-oxyanion leaving group during the cis-cleavage reaction. Strong pH-independent inhibition of ribozyme function also occurs at C75 with a C analogue that lacks the N4 amino group, implicating the exocyclic amine in critical interactions in the active site. Interactions with the amino group may play an important role in perturbing the C75 N3 pK(a). Protonation of C41 has been proposed to be important for ribozyme activity; however, no interference at C41 was observed in this analogue series, which argues against a functional role for C41 protonation. These data support a model wherein C75 of the genomic HDV ribozyme acts as a general acid during its cis-cleavage reaction, and provide a glimpse into how RNAs, in a manner similar to protein enzymes, might employ local environmental electronic modulation to catalyze reactions.
 ...
PMID:pK(a) perturbation in genomic Hepatitis Delta Virus ribozyme catalysis evidenced by nucleotide analogue interference mapping. 1188 83

Orchids have been used as a source of medicine for millennia to treat different diseases and ailments including tuberculosis, paralysis, stomach disorders, chest pain, arthritis, syphilis, jaundice, cholera, acidity, eczema, tumour, piles, boils, inflammations, menstrual disorder, spermatorrhea, leucoderma, diahorrhea, muscular pain, blood dysentery, hepatitis, dyspepsia, bone fractures, rheumatism, asthma, malaria, earache, sexually transmitted diseases, wounds and sores. Besides, many orchidaceous preparations are used as emetic, purgative, aphrodisiac, vermifuge, bronchodilator, sex stimulator, contraceptive, cooling agent and remedies in scorpion sting and snake bite. Some of the preparations are supposed to have miraculous curative properties but rare scientific demonstration available which is a primary requirement for clinical implementations. Incredible diversity, high alkaloids and glycosides content, research on orchids is full of potential. Meanwhile, some novel compounds and drugs, both in phytochemical and pharmacological point of view have been reported from orchids. Linking of the indigenous knowledge to the modern research activities will help to discover new drugs much more effective than contemporary synthetic medicines. The present study reviews the traditional therapeutic uses of orchids with its recent advances in pharmacological investigations that would be a useful reference for plant drug researches, especially in orchids.
 ...
PMID:Therapeutic orchids: traditional uses and recent advances--an overview. 2085 51

Silybin (SIL) and 2,3-dehydrosilybin (DHS) are constituents of milk thistle extract (silymarin) applied in the treatment of cirrhosis, hepatitis, and alcohol-induced liver disease. The molecular mechanism of their action is usually connected with antioxidant action. However, despite experimental and theoretical evidence for the antioxidant activity of SIL and DHS, the mechanism of their antiradical action still remains unclear. We studied the kinetics of SIL/DHS reactions with 2,2-diphenyl-1-picrylhydrazyl radical in organic solutions of different polarity and with peroxyl radicals in a micellar system mimicking the amphiphilic environment of lipid membranes. Kinetic studies together with determination of acidity and electrochemical measurements allowed us to discuss the structure-activity relationship in detail. In nonpolar solvents the reaction with free radicals proceeds via a one-step hydrogen atom transfer (HAT) mechanism, while significant acceleration of the reaction rates in methanol and water/methanol solutions suggests the dominating contribution of a sequential proton-loss electron-transfer (SPLET) mechanism with participation of the most acidic hydroxyl groups: 7-OH in SIL and 7-OH and 3-OH in DHS. In a heterogeneous water/lipid system, both mechanisms operate; however, the reaction kinetics and the antioxidant efficacy depend on the partition between lipid and water phases.
...
PMID:Media effects on the mechanism of antioxidant action of silybin and 2,3-dehydrosilybin: role of the enol group. 2400 1